Services Support
Online inquiry

For Research Use Only. Not For Clinical Use.

Contact us
  • Email:

Whole Genome Sequencing (WGS) Protocol

Overview Materials and Reagents Steps Troubleshooting Related Services FAQs

Creative Biolabs has developed a state-of-the-art WGS protocol tailored to stem cell populations, allowing scientists to trace genomic fidelity, identify subtle variations, and validate engineered cell lines with unmatched precision. Below, we share a detailed protocol that demonstrates not only the technical rigor but also the practicality of our approach.

Overview of Whole Genome Sequencing (WGS) of Stem Cells

Stem cells, particularly pluripotent stem cells (PSCs) and mesenchymal stem cells (MSCs), hold immense potential for basic research, disease modeling, and cell-based product development. However, their genomic stability is often challenged by in vitro culture conditions, genome-editing interventions, or spontaneous mutations over passages.

WGS provides:

  • A complete snapshot of the stem cell genome.
  • Insights into single nucleotide variations (SNVs), structural variants (SVs), and copy number alterations.
  • Detection of rare off-target edits in CRISPR-modified cell lines.
  • Quality assurance for stem cell-derived products before downstream application.

Whole-genome analysis of human embryonic stem cells. (OA Literature)Fig.1 The genomic DNA of hESCs was analyzed by high-density SNP microarray and at the single-nucleotide level by WGS to call structural variants.1,2

The principle of WGS is straightforward yet powerful: fragment the entire stem cell genome, sequence all fragments using next-generation sequencing (NGS) or third-generation long-read platforms, and computationally assemble the full genome to detect variants at single-base resolution.

For stem cells, this principle takes on extra weight because:

  • Genomic instability may compromise differentiation potential.
  • Minor aberrations can expand clonally, altering cell fate.
  • Genome-wide insights surpass targeted panels or karyotyping.

By applying WGS, researchers ensure their stem cell lines maintain fidelity, reproducibility, and translational relevance. Creative Biolabs combines deep sequencing technologies with bioinformatics pipelines optimized for stem cell samples, ensuring researchers receive a holistic and high-resolution genetic profile.

Materials and Reagents

Category Item
Cell Material Human pluripotent stem cells (hESCs or iPSCs)
Mesenchymal stem cells (bone marrow, adipose, cord-derived)
Neural stem cells or other lineage-committed precursors
Reagents & Consumables High-quality DNA extraction kit
RNase A
Nuclease-free water
Fragmentation system (sonicator or enzymatic kit)
DNA quantification reagents
Library preparation kits
Magnetic beads
Sequencing adapters and barcodes
PCR master mix for library amplification

Protocol Steps

Stem Cell Collection and DNA Extraction

Harvest ~1–2 million stem cells under sterile conditions. Extract genomic DNA using a commercial kit optimized for high molecular weight DNA. Treat with RNase A to remove RNA contamination. Quantify DNA and purity check. Verify DNA integrity via agarose gel electrophoresis.

DNA Fragmentation

Shear DNA into fragments (~350 bp for short-read sequencing, >10 kb for long-read). Use ultrasonication or enzymatic fragmentation. Confirm fragment size distribution.

Library Preparation

End-repair fragmented DNA. Perform A-tailing to facilitate adapter ligation. Ligate sequencing adapters containing unique indexes. Purify with magnetic beads to remove small fragments. PCR-amplify (limited cycles to reduce bias).

Whole Genome Sequencing

Load libraries onto NGS platform. Perform paired-end sequencing (150 bp reads). For long-read sequencing, directly load libraries onto Nanopore flow cells.

Data Processing & Bioinformatics

Perform raw data QC. Trim low-quality bases and adapters. Align reads to human reference genome (hg38). Detect SNVs, insertions/deletions, CNVs, and structural variants. Annotate mutations using curated stem cell databases. Generate visual reports for variant distribution and genome integrity.

Troubleshooting and Optimization Tips

We have compiled decades of hands-on experience into a comprehensive troubleshooting guide to help scientists avoid common pitfalls and achieve reliable results.

Problem Solution
Low DNA yield from stem cells
  • Ensure harvesting from actively proliferating cultures rather than senescent cells
  • Avoid repeated freeze–thaw cycles
  • Increasing cell numbers at collection and using DNA isolation kits optimized for high molecular weight DNA can significantly improve yield
Poor DNA integrity
  • Handle samples gently during lysis
  • Use wide-bore pipette tips to prevent shearing
Over-representation of small fragments or adapter dimers
  • Optimize bead-based purification ratios
  • Use dual-size selection to remove both small fragments and oversized fragments
  • Strict quantification avoids overloading adapters
Excessive PCR duplicates leading to reduced coverage diversity
  • Reduce the number of amplification cycles
  • Consider PCR-free library prep methods if sample amount permits
Uneven coverage across the genome
  • Ensure balanced library input and accurate quantification
  • For GC-rich stem cell genomic regions, use sequencing kits with bias-correction chemistries
  • In hybrid strategies, combine short-read and long-read platforms
Low sequencing quality
  • Re-check library prep for contamination
  • Ensure proper calibration of sequencer optics and flow cell loading
  • Always include technical replicates for critical stem cell lines

Optimization Tips for Best Outcomes

  • Always maintain a rigorous QC checkpoint at each stage (DNA, library, sequencing, and analysis).
  • Use matched reference samples (parental cell line or donor DNA) for comparative analysis to identify de novo mutations.
  • For genome-edited stem cells, apply hybrid sequencing (short + long reads) to capture both small-scale and large-scale structural variations.
  • Incorporate bioinformatics cross-validation with orthogonal assays (karyotyping, SNP genotyping) to reinforce conclusions.

Related Services at Creative Biolabs

Our WGS service is part of a comprehensive stem cell characterization platform. Researchers often need multi-dimensional insights that go beyond genomics, and we provide a full suite of complementary assays designed to ensure stem cells meet the highest standards of quality, reproducibility, and application readiness.

Frequently Asked Questions (FAQs)

Q: What sequencing depth is ideal for stem cell WGS?

A: For general quality control, 30× coverage is sufficient. However, for engineered stem cells or projects requiring detection of rare off-target edits and subclonal mutations, we recommend ≥60× coverage. At Creative Biolabs, we adjust depth according to your research goals.

Q: How much starting material do I need for WGS of stem cells?

A: Typically, 1–2 million cells are sufficient to obtain high-quality genomic DNA for bulk sequencing. For single-cell WGS, Creative Biolabs offers ultra-low input library preparation kits and amplification strategies that preserve genomic fidelity.

Q: What types of variants can be detected with WGS?

A: WGS enables identification of single nucleotide variants (SNVs), insertions and deletions (InDels), copy number variations (CNVs), structural variants (SVs), and mitochondrial DNA mutations. Our pipelines are optimized for stem cells, ensuring accurate annotation of variants relevant to genomic stability.

Q: Can Creative Biolabs integrate WGS with other omics services?

A: Definitely. Many clients combine WGS with RNA-Seq, epigenomic profiling, and karyotyping. By leveraging our integrated multi-omics platform, you gain a comprehensive understanding of your stem cells at the genomic, transcriptomic, and epigenetic levels.

References

  1. Merkle, Florian T., et al. "Whole-genome analysis of human embryonic stem cells enables rational line selection based on genetic variation." Cell stem cell 29.3 (2022): 472-486. https://doi.org/10.1016/j.stem.2022.01.011
  2. Distributed under Open Access license CC BY 4.0, without modification.

Created August 2025

For Research Use Only. Not For Clinical Use.